We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates
Comparison of Heparin vs. no Heparin on Duration of Peripherally Inserted Central Catheter Patency in Neonates
Status: Archived
Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates
Updated: 1/1/1970
Comparison of Heparin vs. no Heparin on Duration of Peripherally Inserted Central Catheter Patency in Neonates
Status: Archived
Updated: 1/1/1970
Safety and Efficacy of SeeMore (TM) in Heart Patients
An Open-label, Baseline-Controlled Study of the Safety and Efficacy of SeeMore (TM) (EVP 1001-1 Injection) in Heart Patients
Status: Archived
Safety and Efficacy of SeeMore (TM) in Heart Patients
Updated: 1/1/1970
An Open-label, Baseline-Controlled Study of the Safety and Efficacy of SeeMore (TM) (EVP 1001-1 Injection) in Heart Patients
Status: Archived
Updated: 1/1/1970
Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson
Feasibility of Detecting Myocardial Ischemia by First-pass Contrast MRI Using Regadenoson
Status: Archived
Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson
Updated: 1/1/1970
Feasibility of Detecting Myocardial Ischemia by First-pass Contrast MRI Using Regadenoson
Status: Archived
Updated: 1/1/1970
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Updated: 1/1/1970
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Updated: 1/1/1970
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Updated: 1/1/1970
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Updated: 1/1/1970
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Updated: 1/1/1970
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Updated: 1/1/1970
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Updated: 1/1/1970
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Updated: 1/1/1970
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Study of SilverHawk/TurboHawk in Lower Extremity Vessels (DEFINITIVE LE)
Updated: 1/1/1970
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Status: Archived
Updated: 1/1/1970
Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
A Study to Evaluate the Effect of the Treatment of Anemia on Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
Status: Archived
Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
Updated: 1/1/1970
A Study to Evaluate the Effect of the Treatment of Anemia on Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
Status: Archived
Updated: 1/1/1970
Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)
Coronary Anatomy and Physiology Using Multidetector Dual Source Computed Tomography With Adenosine Enhancement: Comparative Study With SPECT Imaging: Pilot Studies I/II
Status: Archived
Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)
Updated: 1/1/1970
Coronary Anatomy and Physiology Using Multidetector Dual Source Computed Tomography With Adenosine Enhancement: Comparative Study With SPECT Imaging: Pilot Studies I/II
Status: Archived
Updated: 1/1/1970
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
Status: Archived
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
Updated: 1/1/1970
Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis
Status: Archived
Updated: 1/1/1970
Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function
Cardioprotective Synergy of Smoking Cessation and γ-Tocopherol in Restoring Vascular Endothelial Function
Status: Archived
Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function
Updated: 1/1/1970
Cardioprotective Synergy of Smoking Cessation and γ-Tocopherol in Restoring Vascular Endothelial Function
Status: Archived
Updated: 1/1/1970
Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease
Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease
Status: Archived
Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease
Updated: 1/1/1970
Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease
Status: Archived
Updated: 1/1/1970
Clinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery
Clinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery
Status: Archived
Clinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery
Updated: 1/1/1970
Clinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery
Status: Archived
Updated: 1/1/1970
Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery
Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery
Status: Archived
Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery
Updated: 1/1/1970
Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery
Status: Archived
Updated: 1/1/1970
Lipid Rich Necrotic Core Lesion Detected by Cardiac Magnetic Resonance Imaging (CMR)
High Amount of Lipid Rich Necrotic Core Lesion Identified by Pre-interventional Intravascular Ultrasound (IVUS) is Associated With High Rate of Delayed Hyper-enhancement as Detected by Contrast-enhanced Cardiac Magnetic Resonance Imaging
Status: Archived
Lipid Rich Necrotic Core Lesion Detected by Cardiac Magnetic Resonance Imaging (CMR)
Updated: 1/1/1970
High Amount of Lipid Rich Necrotic Core Lesion Identified by Pre-interventional Intravascular Ultrasound (IVUS) is Associated With High Rate of Delayed Hyper-enhancement as Detected by Contrast-enhanced Cardiac Magnetic Resonance Imaging
Status: Archived
Updated: 1/1/1970
Restoration of Atrioventricular Synchrony Trial
Restoration of Atrioventricular Synchrony Trial
Status: Archived
Restoration of Atrioventricular Synchrony Trial
Updated: 1/1/1970
Restoration of Atrioventricular Synchrony Trial
Status: Archived
Updated: 1/1/1970
Restoration of Atrioventricular Synchrony Trial
Restoration of Atrioventricular Synchrony Trial
Status: Archived
Restoration of Atrioventricular Synchrony Trial
Updated: 1/1/1970
Restoration of Atrioventricular Synchrony Trial
Status: Archived
Updated: 1/1/1970
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
Updated: 1/1/1970
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Updated: 1/1/1970
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
Updated: 1/1/1970
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Updated: 1/1/1970
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
Updated: 1/1/1970
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Updated: 1/1/1970
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
Updated: 1/1/1970
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Updated: 1/1/1970
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
Updated: 1/1/1970
CorPath® PRECISE Percutaneous Robotically-Enhanced Coronary Intervention Study (PRECISE)
Status: Archived
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Updated: 1/1/1970
A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System
Status: Archived
Updated: 1/1/1970
Glyburide Advantage in Malignant Edema and Stroke Pilot
A Two-center, Prospective, Open Label, Phase IIa Trial of RP-1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Experience Clinically Significant Brain Swelling.
Status: Archived
Glyburide Advantage in Malignant Edema and Stroke Pilot
Updated: 1/1/1970
A Two-center, Prospective, Open Label, Phase IIa Trial of RP-1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Experience Clinically Significant Brain Swelling.
Status: Archived
Updated: 1/1/1970
Glyburide Advantage in Malignant Edema and Stroke Pilot
A Two-center, Prospective, Open Label, Phase IIa Trial of RP-1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Experience Clinically Significant Brain Swelling.
Status: Archived
Glyburide Advantage in Malignant Edema and Stroke Pilot
Updated: 1/1/1970
A Two-center, Prospective, Open Label, Phase IIa Trial of RP-1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Experience Clinically Significant Brain Swelling.
Status: Archived
Updated: 1/1/1970
Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)
Optima CAD (Optimal Mechanical Evaluation)
Status: Archived
Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)
Updated: 1/1/1970
Optima CAD (Optimal Mechanical Evaluation)
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970
Safety Follow-Up to HP 802-247-09-015
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Safety Follow-Up to HP 802-247-09-015
Updated: 1/1/1970
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015
Status: Archived
Updated: 1/1/1970